[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA924522B - Compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof - Google Patents

Compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof

Info

Publication number
ZA924522B
ZA924522B ZA924522A ZA924522A ZA924522B ZA 924522 B ZA924522 B ZA 924522B ZA 924522 A ZA924522 A ZA 924522A ZA 924522 A ZA924522 A ZA 924522A ZA 924522 B ZA924522 B ZA 924522B
Authority
ZA
South Africa
Prior art keywords
renin
compounds
preparation
inhibiting properties
inhibiting
Prior art date
Application number
ZA924522A
Other languages
English (en)
Inventor
Holger Heitsch
Heitsch Holger
Hansjoerg Urbach
Urbach Hansjoerg
Wolfgang Linz
Linz Wolfgang
Rainer Henning
Henning Rainer
Dieter Ruppert
Ruppert Dieter
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA924522B publication Critical patent/ZA924522B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA924522A 1991-06-21 1992-06-19 Compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof ZA924522B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120510 1991-06-21

Publications (1)

Publication Number Publication Date
ZA924522B true ZA924522B (en) 1993-02-24

Family

ID=6434452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924522A ZA924522B (en) 1991-06-21 1992-06-19 Compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof

Country Status (14)

Country Link
EP (1) EP0519433A1 (es)
JP (1) JPH05186461A (es)
KR (1) KR930000506A (es)
CN (1) CN1068112A (es)
BR (1) BR9202325A (es)
CA (1) CA2071744A1 (es)
CZ (1) CZ190692A3 (es)
FI (1) FI922875A (es)
HU (1) HUT61744A (es)
IE (1) IE921995A1 (es)
MX (1) MX9203070A (es)
NO (1) NO922426L (es)
PL (1) PL294870A1 (es)
ZA (1) ZA924522B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504654A (ja) 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
NZ500351A (en) * 1997-04-14 2001-10-26 Cor Therapeutics Inc Cyclic diaza compounds as selective factor Xa inhibitors
JP2002514214A (ja) 1997-04-14 2002-05-14 シーオーアール セラピューティクス インコーポレイテッド 選択的Ｘａ因子阻害剤
US6204268B1 (en) 1997-04-14 2001-03-20 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
ECSP003707A (es) * 1999-10-13 2002-05-23 Novartis Ag Diazepanes
US6399599B1 (en) 1999-10-13 2002-06-04 Novartis Ag Substituted 2-oxo-1,4-diazacycloalkanes
JP2004518688A (ja) 2001-01-30 2004-06-24 ブリストル−マイヤーズ　スクイブ　カンパニー ファクターＸａ阻害剤のスルホンアミドラクタムおよびその方法
EP1711456A2 (en) * 2004-01-23 2006-10-18 Speedel Experimenta AG Amino alcohol derivatives and their use as renin inhibitors
PT1756037E (pt) 2004-01-23 2011-02-25 Novartis Ag Derivados de aminoálcoois e a sua actividade como inibidores de renina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
GB8707412D0 (en) * 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
IL87614A0 (en) * 1987-09-16 1989-01-31 Abbott Lab Peptidylheterocycles
ATE165085T1 (de) * 1987-09-29 1998-05-15 Banyu Pharma Co Ltd N-acylaminosäurederivate und deren verwendung
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
DE3839559A1 (de) * 1988-11-24 1990-05-31 Hoechst Ag Renin-hemmende aminodiol-derivate
DE3841732A1 (de) * 1988-12-10 1990-06-13 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung
DE3913272A1 (de) * 1989-04-22 1990-10-25 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung

Also Published As

Publication number Publication date
FI922875A (fi) 1992-12-22
CN1068112A (zh) 1993-01-20
BR9202325A (pt) 1993-01-19
NO922426L (no) 1992-12-22
HU9202062D0 (en) 1992-10-28
MX9203070A (es) 1992-12-01
CZ190692A3 (en) 1993-01-13
NO922426D0 (no) 1992-06-19
PL294870A1 (es) 1993-02-08
KR930000506A (ko) 1993-01-15
IE921995A1 (en) 1992-12-30
EP0519433A1 (de) 1992-12-23
HUT61744A (en) 1993-03-01
JPH05186461A (ja) 1993-07-27
FI922875A0 (fi) 1992-06-18
CA2071744A1 (en) 1992-12-22

Similar Documents

Publication Publication Date Title
ZA924522B (en) Compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof
AU2613492A (en) Starch mixture, process for the production thereof and use thereof
ZA915683B (en) Substituted azoles,a process for their preparation and their use
EP0513068A4 (en) Three new non-polyglutamatable deazaaminopterins and process for preparing the same
EP0518156A3 (en) Improved materials based on gypsum, process for their manufacture and their use
EP0285160A3 (en) Fluorine-containing aromatic compound, process for preparing the same and use thereof
EP0622369A3 (de) 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung.
EP0527704A3 (en) Dyestuffs, process for their preparation and the use thereof
ZA924521B (en) Heterocyclic compounds with renin-inhibiting properties,a process for the preparation thereof and the use thereof
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
HUT66140A (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof
IL103142A0 (en) Substituted aminopropanes,processes for their preparation,and their use
EP0432717A3 (en) Azole compounds, their production and use
ZA929374B (en) 2-cyanobenzimidazoles, a process for their preparation and their use, and new precursors.
HRP930131A2 (en) Amino-ascorbic acid derivatives, process for the preparation and use thereof
AU1453492A (en) Antiarteriosclerotic agent, a process for the preparation thereof and the use thereof
ZA92505B (en) Substituted 3-aminosydnone imines,process for the preparation therefore and the use thereof
EP0542217A3 (en) Substituted 1,5-pentanediols and processes for the preparation thereof
EP0549263A3 (en) A process for the preparation of n-alkyl-3,4-dialkyloxyanilines and derivatives thereof
EP0416567A3 (en) Intrinsically electro-conductive polymers, process for preparing the same and use thereof
IL126827A0 (en) Substituted phenyluracils a process for their preparation and the use thereof
IL116967A (en) Ethyl-6-formyloxy-4-hexenoate and process for the preparation thereof
EP0505731A3 (en) Heat-roll and process for manufacturing the same
EP0565195A3 (en) Thermotropic polyesterimide, a process for its preparation, and its use
EP0678293A3 (de) Pyridoxinester enthaltendes Präparat, Verfahren zu dessen Herstellung und dessen Verwendung.